Accuray Incorporated (ARAY)
NASDAQ: ARAY · Real-Time Price · USD
1.490
+0.010 (0.68%)
At close: Aug 13, 2025, 4:00 PM
1.470
-0.020 (-1.35%)
After-hours: Aug 13, 2025, 7:26 PM EDT

Accuray Revenue

In the fiscal year ending June 30, 2025, Accuray had annual revenue of $458.51M with 2.68% growth. Accuray had revenue of $127.54M in the quarter ending June 30, 2025, a decrease of -5.02%.

Revenue (ttm)
$458.51M
Revenue Growth
+2.68%
P/S Ratio
0.33
Revenue / Employee
$464,544
Employees
987
Market Cap
167.84M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 2025458.51M11.95M2.68%
Jun 30, 2024446.55M-1.05M-0.24%
Jun 30, 2023447.61M17.70M4.12%
Jun 30, 2022429.91M33.62M8.48%
Jun 30, 2021396.29M13.36M3.49%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 422.82B
Johnson & Johnson 90.63B
Merck & Co. 63.62B
AbbVie 58.33B
AstraZeneca 56.50B
Novartis AG 55.19B
Eli Lilly and Company 53.26B
Novo Nordisk 49.11B
Revenue Rankings